Xinsong Li Selected Research

protein kinase N

12/2022	Multifunctional Lipid Nanoparticles for Protein Kinase N3 shRNA Delivery and Prostate Cancer Therapy.
1/2022	Efficient delivery of PKN3 shRNA for the treatment of breast cancer via lipid nanoparticles.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xinsong Li Research Topics

Disease

20	Neoplasms (Cancer) 01/2022 - 01/2015
5	Malaria 05/2022 - 01/2018
3	Hemolysis 10/2019 - 01/2018
2	Breast Neoplasms (Breast Cancer) 01/2022 - 04/2019
1	Prostatic Neoplasms (Prostate Cancer) 12/2022
1	Rheumatoid Arthritis 04/2020
1	Rheumatic Fever (Acute Articular Rheumatism) 04/2020
1	Arthritis (Polyarthritis) 04/2020
1	Acute Promyelocytic Leukemia 01/2018
1	Schistosomiasis japonica 01/2014
1	Reinfection 01/2014
1	Infections 01/2014
1	Schistosomiasis (Bilharziasis) 01/2014
1	Carcinoma (Carcinomatosis) 09/2013
1	Glaucoma 01/2010
1	Bone Fractures (Bone Fracture) 02/2007

Drug/Important Bio-Agent (IBA)

14	Liposomes (Liposome)IBA 01/2022 - 05/2015
10	Pharmaceutical PreparationsIBA 11/2021 - 05/2015
5	Phospholipids (Phosphatides)FDA LinkGeneric 05/2022 - 05/2015
5	ArtesunateIBA 05/2022 - 01/2018
4	artemisinin (artemisinine)IBA 05/2022 - 01/2018
4	CamptothecinIBA 09/2021 - 06/2018
4	2- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA 07/2020 - 10/2018
3	Small Interfering RNA (siRNA)IBA 12/2022 - 09/2013
2	Lipid NanoparticlesIBA 12/2022 - 01/2022
2	protein kinase NIBA 12/2022 - 01/2022
2	Type I DNA Topoisomerases (Topoisomerase I)IBA 09/2021 - 10/2018
2	MicellesIBA 03/2021 - 12/2018
2	NanocapsulesIBA 05/2019 - 09/2015
2	DisulfidesIBA 04/2019 - 12/2018
2	Chlorambucil (Leukeran)FDA Link 09/2015 - 05/2015
1	bis(p-chlorophenyl)acetic acid (DDA)IBA 12/2022
1	1,2- diarachidonoyl- glycero- 3- phosphocholineIBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	ArtemisininsIBA 01/2022
1	SolutionsIBA 10/2021
1	Irinotecan (Camptosar)FDA LinkGeneric 09/2021
1	ProdrugsIBA 09/2021
1	SuspensionsIBA 07/2020
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 04/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	LigandsIBA 10/2019
1	Heparin (Liquaemin)FDA LinkGeneric 05/2019
1	Sulfhydryl Compounds (Thiols)IBA 04/2019
1	liposomal doxorubicin (Doxil)FDA Link 04/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2019
1	LipopeptidesIBA 12/2018
1	Biological ProductsIBA 12/2018
1	LipidsIBA 12/2018
1	EnzymesIBA 10/2018
1	trioctyl phosphine oxide (TOPO)IBA 10/2018
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 01/2018
1	Retinoic Acid Receptors (Retinoic Acid Receptor)IBA 01/2018
1	alpha-Tocopherol FDA Link 08/2017
1	Therapeutic UsesIBA 03/2017
1	Betaine (C.B.B.)FDA Link 09/2015
1	Nanoparticle Drug Delivery SystemIBA 09/2015
1	2'-deoxycytidine 5'-triphosphate (dCTP)IBA 05/2015
1	Mechlorethamine (Nitrogen Mustard)FDA Link 01/2015
1	Peptides (Polypeptides)IBA 01/2015
1	Benzoic Acid (Potassium Benzoate)FDA Link 01/2015
1	VaccinesIBA 01/2014
1	DNA VaccinesIBA 01/2014
1	Praziquantel (Biltricide)FDA Link 01/2014
1	Dendrimers (Dendrons)IBA 01/2014
1	PolyethyleneimineIBA 09/2013
1	puerarinIBA 01/2010
1	poly(lactide) (polylactic acid)IBA 02/2007
1	beta-tricalcium phosphateIBA 02/2007

Therapy/Procedure

12	Therapeutics 12/2022 - 05/2015
3	Drug Therapy (Chemotherapy) 06/2017 - 01/2014
2	Lasers (Laser) 07/2020 - 10/2018
1	RNAi Therapeutics 01/2022
1	Oral Administration 10/2018
1	Contact Lenses 01/2010
1	Hydrophilic Contact Lenses (Hydrophilic Contact Lens) 01/2010